Evidence map›Paper›PMID 28831581›Full record

ArticleClinical rheumatology2017

Serum adipokines, adipose tissue measurements and metabolic parameters in patients with advanced radiographic knee osteoarthritis.

Eric Toussirot, Fabrice Michel, Matthieu Béreau, Barbara Dehecq, Béatrice Gaugler, Daniel Wendling, Emilie Grandclément, Philippe Saas, Gilles Dumoulin

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Eric ToussirotINSERM CIC-1431, University Hospital of Besançon, Clinical Investigation Center in Biotherapy, F-25000, Besançon, France. etoussirot@chu-besancon.fr.
Fabrice MichelDepartment of Neuromuscular Examinations and Diseases, University Hospital of Besançon, F-25000, Besançon, France.
Matthieu BéreauDepartment of Neurology, University hospital of Besancon, F-25000, Besançon, France.
Barbara DehecqEndocrine and Metabolic Biochemistry, University Hospital of Besançon, F-, 25000, Besançon, France.
Béatrice GauglerSorbonne Universités, UPMC Univ Paris 06, INSERM UMR938, Centre de Recherche Saint-Antoine (CRSA), F-75012, Paris, France.
Daniel WendlingDepartment of Rheumatology, University Hospital of Besançon, F-25000, Besançon, France.
Emilie GrandclémentEndocrine and Metabolic Biochemistry, University Hospital of Besançon, F-, 25000, Besançon, France.
Philippe SaasINSERM CIC-1431, University Hospital of Besançon, Clinical Investigation Center in Biotherapy, F-25000, Besançon, France.
Gilles DumoulinEndocrine and Metabolic Biochemistry, University Hospital of Besançon, F-, 25000, Besançon, France.
Centre Hospitalier Universitaire de Besançon · FRMethodology and Quality of Life Unit in Oncology · FRSorbonne Université · FRUniversité Bourgogne Franche-Comté · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted the present study to evaluate the serum levels of adipokines (leptin, total and high molecular adiponectin, resistin), a marker of cartilage breakdown (C2C), and ghrelin together with body composition in patients with knee osteoarthritis (OA). Fifty patients and 50 sex-matched healthy subjects (HS) were evaluated. Knee OA was scored according to the Kellgren-Lawrence (KL) grade. Body composition parameters including lean mass and measurements of fat mass (total fat, adiposity, fat in the android and gynoid regions, visceral fat and trunk/legs fat ratio) were obtained using dual energy X-ray absorptiometry. Most of the recruited patients (88%) had advanced knee OA with KL grade 3 or 4. The patients had higher body mass index than HS (p < 0.0001). Serum leptin, high molecular adiponectin, resistin and ghrelin levels did not differ between patients and HS. Total adiponectin was higher in women with OA compared to women from the HS group (p = 0.004). Total fat mass, adiposity and measurements of central adiposity (fat in the android region, trunk/lower limbs fat ratio and visceral fat) were increased in patients with knee OA (all p < 0.05). Total adiponectin was borderline associated with the severity of OA. Our results show that total adiponectin is significantly increased in women with advanced knee OA. Independently of gender, patients with severe knee OA were characterized by a significant excess of fat with a distribution toward the visceral region. This abnormal body composition may contribute to the cardiometabolic profile that is described in patients with knee OA.

Indexed as

Absorptiometry, PhotonAdiponectinAdipose TissueAgedBody CompositionBody Mass IndexFemaleGhrelinHumansLeptinMaleMiddle AgedOsteoarthritis, KneeRadiographyResistinAdiponectinADIPOQ protein, humanGhrelinLeptinResistinRETN protein, humanAdipokinesAdiponectinBody compositionCardiovascular riskKnee osteoarthritisVisceral fat

Identifiers

PMID28831581
OpenAlexW2750460335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.